JP2022543070A5 - - Google Patents
Info
- Publication number
- JP2022543070A5 JP2022543070A5 JP2022506525A JP2022506525A JP2022543070A5 JP 2022543070 A5 JP2022543070 A5 JP 2022543070A5 JP 2022506525 A JP2022506525 A JP 2022506525A JP 2022506525 A JP2022506525 A JP 2022506525A JP 2022543070 A5 JP2022543070 A5 JP 2022543070A5
- Authority
- JP
- Japan
- Prior art keywords
- nanocage
- fusion protein
- fragment
- ferritin
- monomer
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2025154827A JP2026004351A (ja) | 2019-08-01 | 2025-09-18 | 多価及び多重特異性ナノ粒子プラットフォーム及び方法 |
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201962881899P | 2019-08-01 | 2019-08-01 | |
| US62/881,899 | 2019-08-01 | ||
| PCT/CA2020/051061 WO2021016724A1 (en) | 2019-08-01 | 2020-07-31 | Multi-valent and multi-specific nanoparticle platforms and methods |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2025154827A Division JP2026004351A (ja) | 2019-08-01 | 2025-09-18 | 多価及び多重特異性ナノ粒子プラットフォーム及び方法 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2022543070A JP2022543070A (ja) | 2022-10-07 |
| JP2022543070A5 true JP2022543070A5 (https=) | 2023-08-08 |
Family
ID=74228187
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022506525A Pending JP2022543070A (ja) | 2019-08-01 | 2020-07-31 | 多価及び多重特異性ナノ粒子プラットフォーム及び方法 |
| JP2025154827A Pending JP2026004351A (ja) | 2019-08-01 | 2025-09-18 | 多価及び多重特異性ナノ粒子プラットフォーム及び方法 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2025154827A Pending JP2026004351A (ja) | 2019-08-01 | 2025-09-18 | 多価及び多重特異性ナノ粒子プラットフォーム及び方法 |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US20230145060A1 (https=) |
| EP (1) | EP4007779A4 (https=) |
| JP (2) | JP2022543070A (https=) |
| KR (1) | KR20220107151A (https=) |
| CN (3) | CN121449754A (https=) |
| AU (1) | AU2020320459A1 (https=) |
| BR (1) | BR112022001800A2 (https=) |
| CA (1) | CA3149320A1 (https=) |
| MX (1) | MX2022001387A (https=) |
| WO (1) | WO2021016724A1 (https=) |
Families Citing this family (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2021050527A1 (en) * | 2019-09-09 | 2021-03-18 | The Regents Of The University Of California | Compositions and methods for making and using multispecific antibodies |
| CN117157328A (zh) * | 2021-01-28 | 2023-12-01 | 儿童医院 | Multabody构建体、组合物和方法 |
| US20250276070A1 (en) * | 2021-07-12 | 2025-09-04 | The Hospital For Sick Children | Optimized multabody constructs, compositions, and methods |
| KR20240101550A9 (ko) * | 2021-09-13 | 2025-12-10 | 더 호스피탈 포 식 칠드런 | 암 치료용 dr5-표적화 다중체 |
| CN118488971A (zh) * | 2021-09-13 | 2024-08-13 | 儿童医院 | 优化的Multabody构建体、组合物和方法 |
| WO2023060358A1 (en) * | 2021-10-16 | 2023-04-20 | The Hospital For Sick Children | Modified multabody constructs, compositions, and methods |
| EP4416189A4 (en) * | 2021-10-16 | 2025-08-27 | Hospital For Sick Children | MODIFIED MULTIBODY CONSTRUCTS, COMPOSITIONS AND METHODS TARGETING SARS-CoV-2 |
| KR20240043842A (ko) * | 2022-09-27 | 2024-04-04 | 크리포 주식회사 | 주요 아미노산이 전하성 아미노산으로 구성된 펩타이드 태그를 포함하여 자가 조립체를 형성하는 융합 단백질 및 이를 이용하여 재조합 단백질을 정제하는 방법 |
| KR20240043840A (ko) * | 2022-09-27 | 2024-04-04 | 크리포 주식회사 | 주요 아미노산이 전하성 및 극성 아미노산으로 구성된 펩타이드 태그를 포함하여 자가 조립체를 형성하는 융합 단백질 및 이를 이용하여 재조합 단백질을 정제하는 방법 |
| KR102946895B1 (ko) * | 2022-10-21 | 2026-04-02 | 충남대학교산학협력단 | SARS-CoV-2 S1 유래 단백질 및 항체 Fc 영역 단백질을 표면에 동시에 디스플레이하는 페리틴 단백질 구조체 및 이의 코로나바이러스 SARS-CoV-2에 대한 백신 용도 |
| EP4628095A1 (en) * | 2022-11-07 | 2025-10-08 | Xiamen University | Fusion protein and granulated antigen comprising same |
| AU2023407259A1 (en) * | 2022-12-18 | 2025-06-26 | Radiant Biotherapeutics Inc. | Multivalent and multispecific cytokine antagonists |
| KR20250143754A (ko) * | 2022-12-18 | 2025-10-02 | 래디언트 바이오테라퓨틱스 인크. | 다가 조혈 세포 인게이저 또는 활성화제 |
| CN115819626B (zh) * | 2022-12-23 | 2026-04-28 | 北京吉诺卫生物科技有限公司 | 重组铁蛋白纳米颗粒及其制备方法 |
| EP4642797A1 (en) * | 2022-12-28 | 2025-11-05 | BioNTech SE | Rna compositions targeting hiv |
| WO2024254514A1 (en) * | 2023-06-08 | 2024-12-12 | The University Of North Carolina At Chapel Hill | Engineered antibody fusion proteins with modulable binding constants and their applications |
| WO2025054730A1 (en) * | 2023-09-13 | 2025-03-20 | The Hospital For Sick Children | Hiv-1-targeted multabody constructs, compositions, and methods |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1659187A (zh) * | 2002-05-10 | 2005-08-24 | 新世纪药品有限公司 | 融合铁蛋白在疫苗和其他方面的应用 |
| KR20160094550A (ko) * | 2015-01-30 | 2016-08-10 | 동국대학교 산학협력단 | 단일사슬항체조각과 페리틴을 포함하는 융합단백질 및 그의 용도 |
| WO2019023811A1 (en) * | 2017-08-04 | 2019-02-07 | The Hospital For Sick Children | NANOPARTICLE PLATFORM FOR ANTIBODY AND VACCINE DELIVERY |
-
2020
- 2020-07-31 AU AU2020320459A patent/AU2020320459A1/en active Pending
- 2020-07-31 KR KR1020227005980A patent/KR20220107151A/ko active Pending
- 2020-07-31 EP EP20847401.5A patent/EP4007779A4/en active Pending
- 2020-07-31 CN CN202511333631.XA patent/CN121449754A/zh active Pending
- 2020-07-31 BR BR112022001800A patent/BR112022001800A2/pt unknown
- 2020-07-31 CN CN202080069559.3A patent/CN114867754A/zh active Pending
- 2020-07-31 CA CA3149320A patent/CA3149320A1/en active Pending
- 2020-07-31 MX MX2022001387A patent/MX2022001387A/es unknown
- 2020-07-31 CN CN202511333627.3A patent/CN121203033A/zh active Pending
- 2020-07-31 JP JP2022506525A patent/JP2022543070A/ja active Pending
- 2020-07-31 US US17/631,588 patent/US20230145060A1/en active Pending
- 2020-07-31 WO PCT/CA2020/051061 patent/WO2021016724A1/en not_active Ceased
-
2025
- 2025-09-18 JP JP2025154827A patent/JP2026004351A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2022543070A5 (https=) | ||
| US20030198956A1 (en) | Staged assembly of nanostructures | |
| US20040018587A1 (en) | Nanostructures containing antibody assembly units | |
| JP2022526595A5 (https=) | ||
| JP2023504914A5 (https=) | ||
| CN114867754A (zh) | 多价和多特异性纳米颗粒平台和方法 | |
| CN111542534B (zh) | 新型支架式hiv-1疫苗免疫原 | |
| JP2024504777A (ja) | Ｍｕｌｔａｂｏｄｙ構築物、組成物および方法 | |
| JP2023553697A5 (https=) | ||
| US20250263469A1 (en) | Polypeptides targeting sars-cov-2 and related compositions and methods | |
| JP2026004299A5 (https=) | ||
| EP3207064A1 (en) | Methods and compostions involving protein g variants | |
| US20250197481A1 (en) | Antigen Binding Polypeptides, Antigen Binding Polypeptide Complexes and Methods of Use Thereof in HIV | |
| CN116496389A (zh) | 用于治疗hbv感染及相关疾病的表位肽及抗体 | |
| CN102471372A (zh) | 用于抑制HIV进入的α体 | |
| TW201118205A (en) | Phage displaying system expressing single chain antibody | |
| US20250011397A1 (en) | Modified multabody constructs, compositions, and methods targeting sars-cov-2 | |
| US20060275309A1 (en) | Peptide oligomers for use as hiv vaccines | |
| RU2022103853A (ru) | Мультивалентные и мультиспецифические платформы наночастиц и способы | |
| CN116615255A (zh) | 靶向SARS-CoV-2的多肽及相关组合物和方法 | |
| WO2025054730A1 (en) | Hiv-1-targeted multabody constructs, compositions, and methods | |
| CN118488972A (zh) | 经修饰的多抗体构建体、组合物和方法 | |
| Wu | Molecular biorecognition of coiled-coil motifs in the construction of hybrid hydrogels and drug-free macromolecular therapeutics | |
| Konrad | Development of a covalent site-specific antibody labeling strategy by the use of photoactivable Z domains |